DE69328307T2 - Kombination von atovaquone mit proguanil zur behandlung von protozoeninfektion - Google Patents

Kombination von atovaquone mit proguanil zur behandlung von protozoeninfektion

Info

Publication number
DE69328307T2
DE69328307T2 DE69328307T DE69328307T DE69328307T2 DE 69328307 T2 DE69328307 T2 DE 69328307T2 DE 69328307 T DE69328307 T DE 69328307T DE 69328307 T DE69328307 T DE 69328307T DE 69328307 T2 DE69328307 T2 DE 69328307T2
Authority
DE
Germany
Prior art keywords
protozoe
proguanil
atovaquone
infection
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69328307T
Other languages
English (en)
Other versions
DE69328307D1 (de
Inventor
Winston Edward Gutteridge
David Brian Ashton Hutchinson
Victoria Susan Latter
Mary Pudney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10725687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69328307(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of DE69328307D1 publication Critical patent/DE69328307D1/de
Application granted granted Critical
Publication of DE69328307T2 publication Critical patent/DE69328307T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69328307T 1992-11-26 1993-11-25 Kombination von atovaquone mit proguanil zur behandlung von protozoeninfektion Expired - Lifetime DE69328307T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929224739A GB9224739D0 (en) 1992-11-26 1992-11-26 Medicaments
PCT/GB1993/002425 WO1994012164A1 (en) 1992-11-26 1993-11-25 Combination of atovaquone with proguanil for the treatment of protozoal infections

Publications (2)

Publication Number Publication Date
DE69328307D1 DE69328307D1 (de) 2000-05-11
DE69328307T2 true DE69328307T2 (de) 2000-10-26

Family

ID=10725687

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69328307T Expired - Lifetime DE69328307T2 (de) 1992-11-26 1993-11-25 Kombination von atovaquone mit proguanil zur behandlung von protozoeninfektion

Country Status (38)

Country Link
US (3) US5998449A (de)
EP (1) EP0670719B1 (de)
JP (1) JP3768231B2 (de)
KR (1) KR100294802B1 (de)
CN (1) CN1087935C (de)
AP (1) AP517A (de)
AT (1) ATE191340T1 (de)
AU (1) AU685408B2 (de)
BG (1) BG62595B1 (de)
CA (1) CA2150234E (de)
CY (1) CY2193B1 (de)
CZ (2) CZ289171B6 (de)
DE (1) DE69328307T2 (de)
DK (1) DK0670719T3 (de)
ES (1) ES2145114T3 (de)
GB (1) GB9224739D0 (de)
GR (1) GR3033745T3 (de)
HK (1) HK1004468A1 (de)
HU (1) HU225918B1 (de)
IL (1) IL107755A (de)
MX (1) MX9307402A (de)
MY (1) MY114241A (de)
NO (1) NO313225B1 (de)
NZ (1) NZ257901A (de)
OA (1) OA10352A (de)
PE (1) PE55694A1 (de)
PL (1) PL174323B1 (de)
PT (1) PT670719E (de)
RO (1) RO119280B1 (de)
RU (1) RU2108092C1 (de)
SA (1) SA93140434B1 (de)
SG (1) SG45387A1 (de)
SI (1) SI9300614A (de)
SK (1) SK281559B6 (de)
TW (1) TW253835B (de)
UA (1) UA45948C2 (de)
WO (1) WO1994012164A1 (de)
ZA (1) ZA938832B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9424013D0 (en) * 1994-11-29 1995-01-18 Wellcome Found Medicaments
DE19737463A1 (de) * 1997-08-28 1999-03-04 Hoechst Marion Roussel De Gmbh Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden
GB9822681D0 (en) * 1998-10-16 1998-12-09 Vitabiotics Ltd Method of treatment
ES2199817T3 (es) 1999-04-09 2004-03-01 Glaxo Group Limited Preparacion combinada para tratar la malaria.
US7104076B2 (en) * 2004-06-24 2006-09-12 Carrier Corporation Lubricant return schemes for use in refrigerant cycle
ITMI20070941A1 (it) * 2007-05-09 2008-11-10 Chimico Internazi0Nale S P A L Procedimento per la preparazione di naftochinoni trans2,3-disostituiti
ES2517366T3 (es) * 2009-08-20 2014-11-03 Ipca Laboratories Limited Nuevo complejo para el tratamiento y/o profilaxis de infecciones parasitarias
US20180055835A1 (en) 2016-08-25 2018-03-01 Immune Therapeutics Inc. Method for Treating And Preventing Protozoal Infections

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533648A (en) * 1949-03-05 1950-12-12 Joseph H Warburg Circular saw making
NL6411993A (de) * 1963-10-18 1965-04-20
US3347830A (en) * 1964-07-30 1967-10-17 Grace W R & Co Process of polymerizing formaldehyde
GB1141735A (en) * 1966-11-23 1969-01-29 Pfizer & Co C Pharmaceutical anti-tumor composition
NL6817526A (de) * 1968-01-24 1969-07-28
US3655699A (en) * 1970-03-02 1972-04-11 Pfizer Analogues of lapachol as antitumor agents
DE2601458A1 (de) * 1975-01-20 1976-07-22 Ciba Geigy Ag Loesliche, von phenylindandiaminen abgeleitete polyamide
EP0002228B1 (de) * 1977-11-22 1984-02-29 The Wellcome Foundation Limited Hydroxynaphtochinonderivate, ihre Präparate zur Behandlung und Verhütung von Theileriose bei Vieh und Schafen; Verfahren zu deren Herstellung; Naphtochinonderivate
US4485117A (en) * 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
US4485116A (en) * 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
US5053432A (en) * 1983-04-14 1991-10-01 Burroughs Wellcome Co. Naphthoquinone derivatives
JPS59196467A (ja) * 1983-04-23 1984-11-07 Nissan Motor Co Ltd 車輪速及びまたは車輪加減速度検出方法
DE68928964T2 (de) * 1988-08-16 1999-07-29 Wellcome Found Neue Naphthochinone und ihre Anwendung als Arzneimittel
GB8819477D0 (en) * 1988-08-16 1988-09-21 Wellcome Found Medicaments
US5225184A (en) * 1988-08-16 1993-07-06 Burroughs Wellcome Co. Medicaments
US5206268A (en) * 1988-08-16 1993-04-27 Burroughs Wellcome Co. Medicaments
GB8921516D0 (en) * 1989-09-22 1989-11-08 Wellcome Found Medicaments
GB8923254D0 (en) * 1989-10-16 1989-12-06 Wellcome Found Medicaments
US5014737A (en) * 1989-11-13 1991-05-14 Allan Berman Quartz integrated trough/sump recirculating filtered high-purity chemical bath
GB9121316D0 (en) * 1991-10-09 1991-11-20 Wellcome Found Heterocyclic compounds
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
US5529994A (en) * 1993-05-05 1996-06-25 Palo Alto Medical Foundation Treatment for toxoplasmosis
DE69400631T2 (de) * 1993-05-05 1997-02-27 Palo Alto Medical Found Verwendung von rifamycinderivaten zur herstellung eines arzneimittels zur behandlung der toxoplasmose
US5733932A (en) * 1995-01-06 1998-03-31 The Picower Institute For Medical Research Compounds and methods of use to derivatize neighboring lysine residues in proteins under physiological conditions
US5827543A (en) * 1995-12-07 1998-10-27 The Procter & Gamble Company Methods and compositions for the prevention and treatment of urogenital disorders
US5744168A (en) * 1995-12-07 1998-04-28 The Procter & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
US5747476A (en) * 1996-07-17 1998-05-05 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoal myeloencephalitis
ZA983331B (en) * 1997-05-01 1998-10-27 Allegheny University Of The He Method for treating protozoal infections
AUPO821097A0 (en) * 1997-07-25 1997-08-14 Cultor Ltd. A prophylactic
DE19737463A1 (de) * 1997-08-28 1999-03-04 Hoechst Marion Roussel De Gmbh Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden
ES2199817T3 (es) * 1999-04-09 2004-03-01 Glaxo Group Limited Preparacion combinada para tratar la malaria.

Also Published As

Publication number Publication date
NO951995L (no) 1995-07-03
DE69328307D1 (de) 2000-05-11
TW253835B (de) 1995-08-11
MX9307402A (es) 1994-07-29
RO119280B1 (ro) 2004-07-30
EP0670719A1 (de) 1995-09-13
PT670719E (pt) 2000-09-29
JP3768231B2 (ja) 2006-04-19
US6291488B1 (en) 2001-09-18
CN1087935C (zh) 2002-07-24
KR100294802B1 (ko) 2001-09-17
BG99656A (bg) 1996-04-30
CN1091632A (zh) 1994-09-07
HU9501537D0 (en) 1995-07-28
RU2108092C1 (ru) 1998-04-10
CZ289692B6 (cs) 2002-03-13
JPH08503938A (ja) 1996-04-30
AU685408B2 (en) 1998-01-22
GR3033745T3 (en) 2000-10-31
CA2150234C (en) 2001-01-16
PE55694A1 (es) 1995-01-25
US6166046A (en) 2000-12-26
SG45387A1 (en) 1998-01-16
NO951995D0 (no) 1995-05-19
SK57095A3 (en) 1996-05-08
CY2193B1 (en) 2002-11-08
HK1004468A1 (en) 1998-11-27
CZ289171B6 (cs) 2001-11-14
EP0670719B1 (de) 2000-04-05
SK281559B6 (sk) 2001-05-10
AP9300592A0 (en) 1994-01-31
NZ257901A (en) 1997-01-29
NO313225B1 (no) 2002-09-02
MY114241A (en) 2002-09-30
SI9300614A (en) 1994-06-30
BG62595B1 (bg) 2000-03-31
HUT71346A (en) 1995-11-28
PL174323B1 (pl) 1998-07-31
DK0670719T3 (da) 2000-07-31
SA93140434B1 (ar) 2004-09-01
IL107755A0 (en) 1994-02-27
OA10352A (en) 2001-10-22
WO1994012164A1 (en) 1994-06-09
ZA938832B (en) 1995-05-25
CA2150234A1 (en) 1994-06-09
PL309222A1 (en) 1995-10-02
CZ119295A3 (en) 1995-11-15
UA45948C2 (uk) 2002-05-15
IL107755A (en) 2000-10-31
US5998449A (en) 1999-12-07
HU225918B1 (en) 2007-12-28
GB9224739D0 (en) 1993-01-13
CA2150234E (en) 2005-03-22
AU5532294A (en) 1994-06-22
ATE191340T1 (de) 2000-04-15
AP517A (en) 1996-08-23
ES2145114T3 (es) 2000-07-01

Similar Documents

Publication Publication Date Title
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE69318693D1 (de) Magnetischer Konditionierer zur Behandlung von Flüssigkeiten
DE69307509T2 (de) Vorrichtung zur behandlung von herzfehlern
DE69231971D1 (de) Lösungen zur Oberflächenbehandlung von Halbleitern
DE69314334T2 (de) Vorrichtung zur osteosynthese von rückenwirbeln
DE69206341D1 (de) Verfahren zur Behandlung von BCTMP/CTMP-Abwasser.
DE69404785D1 (de) Vorrichtung zur Behandlung von Oberflächen
DE69200684D1 (de) Vorrichtung zur thermischen Behandlung von laufenden Garnen.
DE69328307D1 (de) Kombination von atovaquone mit proguanil zur behandlung von protozoeninfektion
DE69303930T2 (de) Behandlung von mit quecksilber verunreinigtem schlamm
DE69133144T2 (de) Reaktor zur Behandlung von Wafern
DE68911776T2 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
DE69420487T2 (de) Vorrichtung zur thermischen Behandlung von laufenden Garnen
DE69304418T2 (de) Verfahren zur Herstellung von 4,4'-Biphenol
DE69403871D1 (de) Vorrichtung zur Behandlung von Oberflächen
DE69306831D1 (de) Behandlung von Flüssigkeiten
DE69306260T2 (de) Behandlung von abwasser
ATA84689A (de) Einrichtung zur behandlung von gasen
DE69318644D1 (de) Behandlung von Flüssigkeiten
ATE81454T1 (de) Acyl-carnitin zur behandlung und zur verhuetung von virusinfektionen.
DE69413325D1 (de) 24-Epi-1alpha-Hydroxyvitamin D2 zur Behandlung von Osteoporosis
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
DE59209848D1 (de) Verfahren zur Herstellung von 2,4,5-Triamino-6-halogenopyrimidinen und 2-Amino-6-halogenopurinen
DE69424207D1 (de) Gerät zur Behandlung von Blattmaterial
DE59202769D1 (de) Verfahren zur Herstellung von 3-Alkoxycarbonylpropenalen und 3-Dialkoxymethylpropenalen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition